tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HRTX Stock Latest News

Heron Therapeutics Adopts Tax Benefit Preservation Plan
Company AnnouncementsHeron Therapeutics Adopts Tax Benefit Preservation Plan
9d ago
8K
HRTX
Heron Therapeutics adopts tax benefits preservation plan
PremiumThe Fly
Heron Therapeutics adopts tax benefits preservation plan
9d ago
HRTX
Heron Therapeutics’ Earnings Call Highlights Growth and Strategy
PremiumCompany Announcements
Heron Therapeutics’ Earnings Call Highlights Growth and Strategy
12d ago
HRTX
Heron Therapeutics Strengthens Financial Position with Refinancing
PremiumCompany Announcements
Heron Therapeutics Strengthens Financial Position with Refinancing
12d ago
8K
HRTX
Heron Therapeutics Signs Agreement with Patheon
PremiumCompany Announcements
Heron Therapeutics Signs Agreement with Patheon
12d ago
8K
HRTX
Heron Therapeutics Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsHeron Therapeutics Reports Strong Q2 2025 Results
16d ago
HRTX
Heron Therapeutics: Buy Rating Maintained Amid Debt Restructuring and Growth Potential
Premium
Ratings
Heron Therapeutics: Buy Rating Maintained Amid Debt Restructuring and Growth Potential
16d ago
HRTX
Optimistic Outlook on Heron Therapeutics: Strategic Moves and Growth Potential Drive Buy Rating
Premium
Ratings
Optimistic Outlook on Heron Therapeutics: Strategic Moves and Growth Potential Drive Buy Rating
16d ago
HRTX
Morning Movers: Under Armour sinks following second quarter earnings
PremiumThe Fly
Morning Movers: Under Armour sinks following second quarter earnings
16d ago
UA
AMR
Heron Therapeutics Announces Strategic Financial Initiatives
PremiumCompany Announcements
Heron Therapeutics Announces Strategic Financial Initiatives
16d ago
8K
HRTX
Heron Therapeutics reports Q2 EPS (2c), consensus (1c)
PremiumThe Fly
Heron Therapeutics reports Q2 EPS (2c), consensus (1c)
16d ago
HRTX
Heron Therapeutics backs FY25 revenue view $153M-$163M, consensus $158.54M
PremiumThe Fly
Heron Therapeutics backs FY25 revenue view $153M-$163M, consensus $158.54M
16d ago
HRTX
Heron Therapeutics announces capital restructuring
PremiumThe FlyHeron Therapeutics announces capital restructuring
16d ago
HRTX
HTGC
Heron Therapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
Heron Therapeutics Holds Annual Stockholders Meeting
2M ago
8K
HRTX
Edison, Apple, Oklo, Heron, Fifth Third: Trending by Analysts
Premium
Weekend Updates
Edison, Apple, Oklo, Heron, Fifth Third: Trending by Analysts
2M ago
EIX
APLE
Heron Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Heron Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
HRTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
BOLT
HRTX
Heron Therapeutics: Strong Q1 Performance and Product Portfolio Growth Reinforce Buy Rating
PremiumRatings
Heron Therapeutics: Strong Q1 Performance and Product Portfolio Growth Reinforce Buy Rating
4M ago
HRTX
Heron Therapeutics Reports Strong Q1 2025 Results
PremiumCompany Announcements
Heron Therapeutics Reports Strong Q1 2025 Results
4M ago
HRTX
Heron Therapeutics Q1 2025 Earnings: Strong Growth Amid Challenges
PremiumCompany AnnouncementsHeron Therapeutics Q1 2025 Earnings: Strong Growth Amid Challenges
4M ago
HRTX
Heron Therapeutics Settles Patent Dispute with Mylan
Premium
Company Announcements
Heron Therapeutics Settles Patent Dispute with Mylan
4M ago
8K
HRTX
Heron Therapeutics raises FY25 adjusted EBITDA view to $4M-$12M from $0-$8M
Premium
The Fly
Heron Therapeutics raises FY25 adjusted EBITDA view to $4M-$12M from $0-$8M
4M ago
HRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >